Beta-adrenergic blocking agent in cardiovascular disease: focus on metoprolol
This article presents the data on the therapeutic efficacy ofbeta-adrenergic blocking agentsin ischemic heart disease, chronic heart failure (CHF), arterial hypertension. We analyzed the basic pharmacological mechanism of action of these drugs class. The comparison of pharmacodynamic and pharmacokin...
Main Authors: | G A Baryshnikov, I I Stepanova, N A Kudryavtseva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Morozov P.V.
2014-09-01
|
Series: | Системные гипертензии |
Subjects: | |
Online Access: | https://syst-hypertension.ru/2075-082X/article/viewFile/29049/pdf |
Similar Items
-
The Beta3 Adrenergic Receptor in Healthy and Pathological Cardiovascular Tissues
by: Lauriane Y. M. Michel, et al.
Published: (2020-12-01) -
Regulation of bone formation and resorption by Beta Adrenergic system
by: Fateme Mohammadali, et al.
Published: (2016-04-01) -
Beta adrenergic blokade in myocardial infarction
by: Yusuf, S
Published: (1980) -
Adrenergic Receptors and Metabolism: Role in development of cardiovascular disease
by: Michele eCiccarelli, et al.
Published: (2013-10-01) -
Beta adrenergic blockers poisoning
by: Tadić Milorad, et al.
Published: (2016-01-01)